Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
D001095:Arachidonic Acids / Q000097:blood*; D001792:Blood Platelets / Q000378:metabolism*; D002855:Chromatography, Thin Layer; D003094:Collagen / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated / Q000096:biosynthesis* / Q000097:blood; D006801:Humans; D006880:Hydroxy Acids / Q000096:biosynthesis* / Q000097:blood; D007093:Imidazoles / Q000494:pharmacology*; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis* / Q000097:blood; D011458:Prostaglandins E / Q000494:pharmacology*; D011463:Prostaglandins H / Q000097:blood; D013928:Thromboxane A2 / Q000096:biosynthesis*; D013931:Thromboxanes / Q000096:biosynthesis*
D001095:Arachidonic Acids; D005231:Fatty Acids, Unsaturated; D006880:Hydroxy Acids; D007093:Imidazoles; D011453:Prostaglandins; D011458:Prostaglandins E; D011463:Prostaglandins H; D013931:Thromboxanes; C008033:12-hydroxy-5,8,10-heptadecatrienoic acid; D013928:Thromboxane A2; D003094:Collagen